Get Live Data

GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. Oxford Cann Share Price
  4. Oxford Cann Share Regulatory News
  5. Oxford Cannabinoid Technologies appoints new CEO

Pin to quick picksOxford Cann Regulatory News (OCTP)

Oxford Cann Information

Share Price Information for Oxford Cann (OCTP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.10
Ask: 0.13
Change: -0.005 (-4.17%)
Spread: 0.03 (30.00%)
Open: 0.12
High: 0.18
Low: 0.115
Prev. Close: 0.115
OCTP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Cannabinoid Technologies appoints new CEO

5 Dec 2022 14:39

Oxford Cannabinoid Technologies Holdings PLC Oxford Cannabinoid Technologies appoints new CEO 05.12.2022 / 15:38 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

05.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:Oxford Cannabinoid Technologies Holdings PLC
United States
ISIN:GB00BMVMRB86
EQS News ID:1505463
 
End of NewsEQS News Service

1505463 05.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

123
Date   Source Headline
6th Jun 20247:00 amRNSCancellation of Listing
31st May 20247:00 amRNSUpdated Shareholder Engagement
17th May 20244:30 pmRNSUpdated Shareholder Information
8th May 20247:00 amRNSIntended Cancellation of Listing
11th Apr 202411:26 amRNSAppointment of Phase I Clinical Trial CRO
3rd Apr 20248:00 amRNSOCT Company Update with Doceo
26th Mar 202410:56 amRNSOxford Cannabinoid Technologies video with Doceo
18th Mar 20247:00 amRNSAppointment of Hybridan as Adviser
29th Feb 20247:02 amRNSDirectorate Appointment
29th Feb 20247:01 amRNSDirectorate Changes
29th Feb 20247:00 amRNSTotal Voting Rights
28th Feb 20245:35 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
28th Feb 20245:34 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
28th Feb 20245:34 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
26th Feb 20241:07 pmRNSDirectors’ Dealings
19th Feb 20241:52 pmRNSResult of General Meeting
16th Feb 20247:00 amRNSCompletion of Capital Reorganisation
15th Feb 20247:00 amRNSSubscription
14th Feb 202412:53 pmRNSCapital Reorganisation
9th Feb 20247:00 amRNSEdison issues update on OCTP
2nd Feb 20243:17 pmRNSNotice of General Meeting & Posting of Circular
2nd Feb 20243:13 pmRNSConvertible Loan Note Agreements
30th Jan 20247:04 amRNSFundraising and Proposed Capital Reorganisation
30th Jan 20247:02 amRNSR&D Tax Credit
30th Jan 20247:00 amRNSHalf-year Report
23rd Jan 20247:00 amRNSNotice of Results
10th Jan 20247:00 amRNSPatent Applications
14th Nov 20237:00 amRNSDirectorate Appointment
24th Oct 20237:00 amRNSTR-1: Notification of major holdings
20th Oct 20237:01 amRNSTR-1: Notification of major holdings
20th Oct 20237:00 amRNSDirector Dealing
10th Oct 20237:00 amRNSPhase I Clinical Trial Results
29th Sep 20237:00 amRNSResult of AGM
25th Sep 20237:00 amRNSFinal Dose Administered
5th Sep 20234:18 pmRNSNotice of AGM
31st Aug 20237:00 amRNS2023 Final Results
22nd Aug 20237:00 amRNSNotice of Results
27th Jul 20237:00 amRNSFirst Dose Administered & Pain Specialist Adviser
17th Jul 20231:16 pmRNSDirector/PDMR Share Purchases
17th Jul 20237:00 amRNSExpansion into oncology
12th Jul 20237:00 amRNSInvestor Presentation and Q&A – Programmes update
15th Jun 20239:50 amRNSOCTP update from Doceo
8th Jun 20237:00 amRNSAppointment of Chief Medical Officer
17th May 20237:00 amRNSMHRA & REC 2 Approval for Phase 1 Clinical Trial
12th Apr 20237:00 amRNSDirectorate Change, Renewal of Licence & Update
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
7th Mar 202311:05 amRNSSecond Price Monitoring Extn
7th Mar 202311:00 amRNSPrice Monitoring Extension
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.